Search Resources (English): Clinical trials

Results 1 - 10 of 21

Results

Outreach notebook for the NIH guidelines on inclusion of women and minorities as subjects in clinical research

Developed in response to the 1994 NIH guidelines on the inclusion of women and minorities in clinical research. Seeks to address potential issues that may arise as a result of NIH's attempt to recruit greater numbers of women and minorities into clinical studies in an attempt to more accurately reflect these groups in medical studies. Developed to provide guidance of key issues in the recruitment and retention of individuals into studies to investigators and their research teams.

Inclusion of women in clinical trials: therapeutic products programme guidelines  
http://www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/guides/clintrls/wominct_e.html

Details guidelines to ensure that women are enrolled in clinical trials at all stages of drug development in order to define the risks and benefits associated with drug therapy.

 (See Details)
Published: 1997
IVF effectiveness: first the burden of illness, then the burden of cost  
http://www.iaac.ca/en/library

Discusses the two premises on which governments have not provided funding for medical treatments of infertile couples. Governments claim fertilization is not medically necessary, and infertility treatments, particularly in vitro fertilization (IVF), are not effective. Current study being done seeks to provide evidence against the latter premise; this up-to-date and valid assessment of IVF effectiveness will provide vital information for policy-makers, clinicians and patients.

 (See Details)
Opening the medicine cabinet: first report on health aspects of prescription drugs: report of the Standing Committee on Health  
http://www.parl.gc.ca/InfocomDoc/Documents/37/3/parlbus/commbus/house/reports/healrp01-e.htm
Provides a study of the health aspects of prescription drugs in Canada. Addresses issues relevant to prescription drugs in Canada. Includes recommendations. (See Details)
Published: 2004
NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research  
http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm
Provides guidelines to ensure that all NIH-funded clinical research will be carried out in a manner sufficient to elicit information about individuals of both sexes/genders and diverse racial and ethnic groups. (See Details)
Published: 2001
Practical and ethical dilemmas in the clinical testing of microbicides: a report on a symposium
Describes microbicides, substances that would reduce the transmission of sexually transmitted infections (STIs) when used vaginally or rectally. Summarizes extensive deliberations, key decisions and recommendations made at a 1997 symposium of 55 advocates, scientists, policy makers, and industry representatives from 15 countries across Africa, Asia, Latin America, Europe, and the United States. Addresses such complex issues as informed consent, standard of care, community participation, the role of social science, and implications for public policy.
Published: 1998
Women's health research in Canada  
http://www.hc-sc.gc.ca/hl-vs/pubs/women-femmes/can-usa/can-back-promo_8_e.html
Discusses women’s health research in Canada and addresses issues such as the involvement of women in research and clinical trials. Prepared for the Canada-U.S.A. Women's Health Forum, Ottawa, ON, 1996 (CANUSA). (See Details)
Published: 1996
Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of effica  
http://www.ccohta.ca/publications/pdf/117_raloxifene_tr_e.pdf
Evaluates the safety and efficacy of raloxifene compared with placebo and other drugs approved in Canada for the primary and secondary prevention of osteoporotic vertebral fractures in postmenopausal women. (See Details)
Published: 2005
When clinical trials are compromised: a perspective from a patient advocate  
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020358
Examines how the rush to approve experimental treatments before appropriate clinical trials can lead to increased suffering and death. (See Details)
Published: 2005
Use of antibiotic in contraceptive trial sparks controversy  
http://bmj.bmjjournals.com/cgi/content/full/328/7433/188-a?etoc
Examines a clinical trial held in India that evaluated the antibiotic erythromycin as a female contraceptive. Argues that the study was unethical that it highlights the ease with which illegal clinical trials may be conducted on unsophisticated, vulnerable populations in India. (See Details)
Published: 2004